Four BRAF-V600/NRAS mutant pre-treated patients with locally advanced or metastatic melanoma and one patient (#A30) with de novo metastases during adjuvant therapy for radically resected BRAF-V600/NRAS wild-type melanoma were tested. The gene discussed is NRAS; the disease is metastatic melanoma.